Flamel Technologies SA (FLML) Stock Price Down 3.4%
Shares of Flamel Technologies SA (NASDAQ:FLML) traded down 3.4% on Wednesday . The company traded as low as $13.27 and last traded at $13.46, with a volume of 105,009 shares trading hands. The stock had previously closed at $13.94.
Separately, Zacks Investment Research upgraded Flamel Technologies SA from a “sell” rating to a “hold” rating in a research note on Tuesday, July 12th. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Flamel Technologies SA presently has a consensus rating of “Buy” and a consensus target price of $18.63.
The stock has a 50-day moving average of $13.62 and a 200 day moving average of $11.57. The stock has a market cap of $562.53 million, a P/E ratio of 33.03 and a beta of 1.42.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/flamel-technologies-sa-flml-stock-price-down-3-4.html
Flamel Technologies SA (NASDAQ:FLML) last announced its quarterly earnings results on Monday, August 8th. The company reported ($0.02) earnings per share for the quarter, missing analysts’ consensus estimates of $0.06 by $0.08. Flamel Technologies SA had a return on equity of 25.19% and a net margin of 12.11%. The business had revenue of $38.90 million for the quarter, compared to analysts’ expectations of $32.80 million. During the same period last year, the company posted $0.34 earnings per share. The firm’s revenue for the quarter was down 20.0% on a year-over-year basis. On average, equities research analysts forecast that Flamel Technologies SA will post ($1.11) EPS for the current year.
In other Flamel Technologies SA news, Director Craig R. Stapleton purchased 20,000 shares of the firm’s stock in a transaction that occurred on Friday, August 26th. The stock was purchased at an average cost of $13.76 per share, with a total value of $275,200.00. Following the transaction, the director now owns 509,678 shares in the company, valued at $7,013,169.28. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Craig R. Stapleton purchased 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 1st. The shares were acquired at an average cost of $13.52 per share, with a total value of $135,200.00. Following the completion of the transaction, the director now owns 519,678 shares in the company, valued at approximately $7,026,046.56. The disclosure for this purchase can be found here. Corporate insiders own 4.45% of the company’s stock.
A number of hedge funds have recently made changes to their positions in FLML. Janus Capital Management LLC boosted its stake in shares of Flamel Technologies SA by 647.0% in the second quarter. Janus Capital Management LLC now owns 2,197,404 shares of the company’s stock worth $25,599,000 after buying an additional 1,903,256 shares during the period. Acadian Asset Management LLC boosted its stake in shares of Flamel Technologies SA by 240.2% in the second quarter. Acadian Asset Management LLC now owns 1,617,223 shares of the company’s stock worth $17,372,000 after buying an additional 1,141,783 shares during the period. Falcon Point Capital LLC boosted its stake in shares of Flamel Technologies SA by 1.1% in the second quarter. Falcon Point Capital LLC now owns 1,015,841 shares of the company’s stock worth $10,910,000 after buying an additional 10,973 shares during the period. Brown Capital Management LLC boosted its stake in shares of Flamel Technologies SA by 36.5% in the second quarter. Brown Capital Management LLC now owns 790,206 shares of the company’s stock worth $8,487,000 after buying an additional 211,392 shares during the period. Finally, Emerald Acquisition Ltd. acquired a new stake in shares of Flamel Technologies SA during the second quarter worth $6,530,000. 70.33% of the stock is owned by hedge funds and other institutional investors.
About Flamel Technologies SA
Flamel Technologies SA is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its polymer based technology. The Company has a balanced business model consisting of an Unapproved Marketed Drugs (UMDs) business with over two approved products in the United States, Bloxiverz (neostigmine methylsulfate injection) and Vazculep (phenylephrine hydrochloride injection) that are marketed; a branded pediatric business, and a branded business, focusing on the development of products utilizing Flamel’s drug delivery platforms.
Receive News & Ratings for Flamel Technologies SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Flamel Technologies SA and related companies with MarketBeat.com's FREE daily email newsletter.